1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Standard DLI: new trials by email Literature Review of Standard DLI trials Research Report on Standard DLI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells T-reg depleted DLI, Standard DLI - Hematological Malignancies, Regulatory T Cell Depletion | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 52 | 2018-02-22 | 2023-12-18 |
Hematologic Neoplasms (1) · Recurrence (1)
Assistance Publique - Hôpitaux de Paris (1)
France (1)